Metastatic HR+/HER2- Breast Cancer
ASCO 2023: Oncolytics Unleashes Revolutionary Results for Breast Cancer Immunotherapy
SG Tylor
ABSTRACT NUMBER – 1012 Preclinical studies have demonstrated that the oncolytic reovirus Pelareorep can enhance the tumor microenvironment by promoting ...
